LICENCE AGREEMENTLicence Agreement • March 10th, 2021 • Achilles Therapeutics PLC • Biological products, (no disgnostic substances) • England
the course of and ongoing performance of the TRACERx Study in other fields as specified in this Agreement, as well as a right to negotiate for a licence over Founders IP which will arise after the Effective Date for a defined period, in each case upon the terms of this Agreement, and CRT wishes to grant such rights to AchillesTx and does so with the consent and support of UCL, UCLB, CRICK, CS, KP and SQ.
